Dr Andrew Joseph Cefalu Jr, DC | |
2470 Flowood Dr., Suite 125, Flowood, MS 39232 | |
(601) 932-9201 | |
(601) 932-4962 |
Full Name | Dr Andrew Joseph Cefalu Jr |
---|---|
Gender | Male |
Speciality | Chiropractic |
Experience | 18 Years |
Location | 2470 Flowood Dr., Flowood, Mississippi |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1144265174 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
111N00000X | Chiropractor | CHIR008002 (Georgia) | Secondary |
111N00000X | Chiropractor | 1143 (Mississippi) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Cefalu Chiropractic Services Of Madison Llc | 1557739596 | 2 |
News Archive
A variety of smoking cessation treatments are currently available for the more than 18 million adult Americans try to quit smoking each year, but success rates vary widely. Despite the importance of quitting smoking, more personalized approaches to smoking cessation treatment are needed to help smokers pick the right method that will work best for them. A major new personalized medicine clinical trial, led by addiction researchers at the University of Pennsylvania, will study how a smokers' genetic make-up influences their quitting success.
It has been a common opinion that inflammation in adipose tissue may cause insulin resistance, and thereby type 2 diabetes. However, recent research from the Swedish medical university Karolinska Institutet, published in the New England Journal of Medicine, question the theory that inflammation in the body fat is only pernicious.
Bloomberg: "Eight U.S. senators, along with Representative John Boehner and 35 economists, won the right to submit their arguments in a lawsuit by 20 states seeking to undo the Obama administration's health-care overhaul. U.S. District Judge Roger Vinson in Pensacola yesterday granted requests by the eight Republican members of Congress and the economists to offer their views on the administration's bid to have the suit thrown out.
Currently, the best way to predict whether a breast cancer is likely to recur is to determine whether tumor cells have invaded the lymph nodes near the breast.
Agios Pharmaceuticals, Inc., a leader in the fields of cancer metabolism and inborn errors of metabolism (IEM), today announced dose administration of AG-348 in a Phase 1 study in healthy volunteers.
› Verified 7 days ago
Provider Name | Foxworth Chiropractic |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1770530248 PECOS PAC ID: 8325141252 Enrollment ID: O20070314000498 |
News Archive
A variety of smoking cessation treatments are currently available for the more than 18 million adult Americans try to quit smoking each year, but success rates vary widely. Despite the importance of quitting smoking, more personalized approaches to smoking cessation treatment are needed to help smokers pick the right method that will work best for them. A major new personalized medicine clinical trial, led by addiction researchers at the University of Pennsylvania, will study how a smokers' genetic make-up influences their quitting success.
It has been a common opinion that inflammation in adipose tissue may cause insulin resistance, and thereby type 2 diabetes. However, recent research from the Swedish medical university Karolinska Institutet, published in the New England Journal of Medicine, question the theory that inflammation in the body fat is only pernicious.
Bloomberg: "Eight U.S. senators, along with Representative John Boehner and 35 economists, won the right to submit their arguments in a lawsuit by 20 states seeking to undo the Obama administration's health-care overhaul. U.S. District Judge Roger Vinson in Pensacola yesterday granted requests by the eight Republican members of Congress and the economists to offer their views on the administration's bid to have the suit thrown out.
Currently, the best way to predict whether a breast cancer is likely to recur is to determine whether tumor cells have invaded the lymph nodes near the breast.
Agios Pharmaceuticals, Inc., a leader in the fields of cancer metabolism and inborn errors of metabolism (IEM), today announced dose administration of AG-348 in a Phase 1 study in healthy volunteers.
› Verified 7 days ago
Provider Name | Cefalu Chiropractic Services Of Madison Llc |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1215659677 PECOS PAC ID: 1557739596 Enrollment ID: O20221122001809 |
News Archive
A variety of smoking cessation treatments are currently available for the more than 18 million adult Americans try to quit smoking each year, but success rates vary widely. Despite the importance of quitting smoking, more personalized approaches to smoking cessation treatment are needed to help smokers pick the right method that will work best for them. A major new personalized medicine clinical trial, led by addiction researchers at the University of Pennsylvania, will study how a smokers' genetic make-up influences their quitting success.
It has been a common opinion that inflammation in adipose tissue may cause insulin resistance, and thereby type 2 diabetes. However, recent research from the Swedish medical university Karolinska Institutet, published in the New England Journal of Medicine, question the theory that inflammation in the body fat is only pernicious.
Bloomberg: "Eight U.S. senators, along with Representative John Boehner and 35 economists, won the right to submit their arguments in a lawsuit by 20 states seeking to undo the Obama administration's health-care overhaul. U.S. District Judge Roger Vinson in Pensacola yesterday granted requests by the eight Republican members of Congress and the economists to offer their views on the administration's bid to have the suit thrown out.
Currently, the best way to predict whether a breast cancer is likely to recur is to determine whether tumor cells have invaded the lymph nodes near the breast.
Agios Pharmaceuticals, Inc., a leader in the fields of cancer metabolism and inborn errors of metabolism (IEM), today announced dose administration of AG-348 in a Phase 1 study in healthy volunteers.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Andrew Joseph Cefalu Jr, DC 2470 Flowood Dr., Suite 125, Flowood, MS 39232 Ph: (601) 932-9201 | Dr Andrew Joseph Cefalu Jr, DC 2470 Flowood Dr., Suite 125, Flowood, MS 39232 Ph: (601) 932-9201 |
News Archive
A variety of smoking cessation treatments are currently available for the more than 18 million adult Americans try to quit smoking each year, but success rates vary widely. Despite the importance of quitting smoking, more personalized approaches to smoking cessation treatment are needed to help smokers pick the right method that will work best for them. A major new personalized medicine clinical trial, led by addiction researchers at the University of Pennsylvania, will study how a smokers' genetic make-up influences their quitting success.
It has been a common opinion that inflammation in adipose tissue may cause insulin resistance, and thereby type 2 diabetes. However, recent research from the Swedish medical university Karolinska Institutet, published in the New England Journal of Medicine, question the theory that inflammation in the body fat is only pernicious.
Bloomberg: "Eight U.S. senators, along with Representative John Boehner and 35 economists, won the right to submit their arguments in a lawsuit by 20 states seeking to undo the Obama administration's health-care overhaul. U.S. District Judge Roger Vinson in Pensacola yesterday granted requests by the eight Republican members of Congress and the economists to offer their views on the administration's bid to have the suit thrown out.
Currently, the best way to predict whether a breast cancer is likely to recur is to determine whether tumor cells have invaded the lymph nodes near the breast.
Agios Pharmaceuticals, Inc., a leader in the fields of cancer metabolism and inborn errors of metabolism (IEM), today announced dose administration of AG-348 in a Phase 1 study in healthy volunteers.
› Verified 7 days ago
Dr. Susan Neely Berry, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 2470 Flowood Dr, Suite 125, Flowood, MS 39232 Phone: 601-932-9201 | |
Brumfield Chiropractic Chiropractor Medicare: Medicare Enrolled Practice Location: 1080 River Oaks Dr Ste B103, Flowood, MS 39232 Phone: 601-291-8362 Fax: 601-586-8400 | |
Dr. Clayton Lowery Pitts, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 1000 Lakeland Square Ext Ste 400, Flowood, MS 39232 Phone: 601-932-3855 Fax: 601-956-8865 | |
Cefalu Chiropractic Services Of Madison, Llc Chiropractor Medicare: Medicare Enrolled Practice Location: 2470 Flowood Dr Ste 125, Flowood, MS 39232 Phone: 601-932-9201 Fax: 601-932-4962 | |
Dr. Chad A Brown, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 4294 Lakeland Dr, Suite 100, Flowood, MS 39232 Phone: 601-936-6650 | |
Pre-hab, Llc Chiropractor Medicare: Medicare Enrolled Practice Location: 1000 Lakeland Square Ext Ste 400, Flowood, MS 39232 Phone: 601-932-3855 Fax: 601-932-6557 |